EP4243825
OMECAMTIV MECARBIL TIL MEÐFERÐAR VIÐ HJARTABILUN Í TILTEKNUM SJÚKLINGAHÓPUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
11.11.2021EP published:
12.11.2025EP application number:
21820408.9
EP translation filed:
18.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
10.11.2041Expiry date:
10.11.2026
Title in English:
OMECAMTIV MECARBIL FOR THE TREATMENT OF HEART FAILURE IN SELECTED PATIENT GROUPSLanguage of the patent:
English
Timeline
Today
11.11.2021EP application
12.11.2025EP Publication
18.12.2025Translation submitted
14.1.2026Registration published
10.11.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, California 91320, US
Name:
Cytokinetics, Inc.Address:
350 Oyster Point Blvd, South San Francisco CA 94080, US
Inventor
Name:
HONARPOUR, NarimonAddress:
Thousand Oaks, California 91320-1799, US
Name:
MALIK, FadyAddress:
South San Francisco, California 94080, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202063112995 PDate:
12.11.2020Country:
US
Number:
202163154077 PDate:
26.2.2021Country:
US
Number:
202163187084 PDate:
11.5.2021Country:
US
Number:
202163202873 PDate:
28.6.2021Country:
US
Number:
202163203436 PDate:
22.7.2021Country:
US
Classification
Categories:
A61K 31/496, A61K 45/06, A61K 9/00, A61P 9/04, A61P 7/04, A61P 9/10, A61K 9/20